DUSTTON WALKER: Open Payments
NPI 1285183616 · MADISONVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 33 payments from 7 companies in 2025. Trend: 2023 $570 · 2024 $279 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $263 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $160 |
| Corium, LLC | 6 | $106 |
| Lundbeck LLC | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: INGREZZA, CAPLYTA, Azstarys, REXULTI, RELISTOR, INCEPTIV, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
